P/E ratio for ICU Medical (ICUI)
P/E ratio as of May 2023 (TTM): -90.1
According to ICU Medical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -90.1406. At the end of 2021 the company had a P/E ratio of 48.7.
P/E ratio history for ICU Medical from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 48.7 | -5.71% |
| 2020 | 51.7 | 35.62% |
| 2019 | 38.1 | -76.43% |
| 2018 | 162 | 172.51% |
| 2017 | 59.3 | 51.42% |
| 2016 | 39.2 | -1.32% |
| 2015 | 39.7 | -16.12% |
| 2014 | 47.3 | |
| 2012 | 21.0 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Baxter BAX | -8.56 | -90.51% | 🇺🇸 USA |
 Becton Dickinson BDX | 45.0 | -149.96% | 🇺🇸 USA |
 Edwards Lifesciences EW | 34.0 | -137.75% | 🇺🇸 USA |
 Teleflex TFX | 30.1 | -133.38% | 🇺🇸 USA |
 Merit Medical MMSI | 55.0 | -161.02% | 🇺🇸 USA |
 AngioDynamics ANGO | -9.86 | -89.07% | 🇺🇸 USA |
 Insulet PODD | > 1000 | -30,330.55% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.